Stable one-step technetium-99m labeling of His-tagged recombinant proteins with a novel Tc(I)–carbonyl complex

We have developed a technetium labeling technology based on a new organometallic chemistry, which involves simple mixing of the novel reagent, a 99mTc(I)–carbonyl compound, with a His-tagged recombinant protein. This method obviates the labeling of unpaired engineered cysteines, which frequently create problems in large-scale expression and storage of disulfide-containing proteins. In this study, we labeled antibody single-chain Fv fragments to high specific activities (90 mCi/mg), and the label was very stable to serum and all other challenges tested. The pharmacokinetic characteristics were indistinguishable from iodinated scFv fragments, and thus scFV fragments labeled by the new method will be suitable for biodistribution studies. This novel labeling method should be applicable not only to diagnostic imaging with 99mTc, but also to radioimmunotherapy approaches with 186/188Re, and its use can be easily extended to almost any recombinant protein or synthetic peptide.

[1]  Tristan J. Vaughan,et al.  Human Antibodies with Sub-nanomolar Affinities Isolated from a Large Non-immunized Phage Display Library , 1996, Nature Biotechnology.

[2]  David M. Goldenberg,et al.  Reducing the renal uptake of radiolabeled antibody fragments and peptides for diagnosis and therapy: present status, future prospects and limitations , 1998, European Journal of Nuclear Medicine.

[3]  G. Wilkinson,et al.  Alkylimido and oxo aryls of rhenium. X-ray structures of (BuittN)2ReCl2(o-MeC6H4) and MO2(2,6-Me2C6H3)2, M = Re and Os , 1988 .

[4]  K. Chester,et al.  Technetium-99m radiolabeling using a phage-derived single-chain Fv with a C-terminal cysteine. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  J. McCafferty,et al.  Antibody engineering: a practical approach , 1997 .

[6]  I. Pastan,et al.  Biodistribution of 18F- and 125I-labeled anti-Tac disulfide-stabilized Fv fragments in nude mice with interleukin 2 alpha receptor-positive tumor xenografts. , 1995, Cancer research.

[7]  E. Kremmer,et al.  Specific detection of his-tagged proteins with recombinant anti-His tag scFv-phosphatase or scFv-phage fusions. , 1997, BioTechniques.

[8]  L L Houston,et al.  Radiometal labeling of recombinant proteins by a genetically engineered minimal chelation site: technetium-99m coordination by single-chain Fv antibody fusion proteins through a C-terminal cysteinyl peptide. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[9]  G. Adams,et al.  Increased affinity leads to improved selective tumor delivery of single-chain Fv antibodies. , 1998, Cancer research.

[10]  R. Wallace.  Is this a practical approach? , 2001, Journal of the American College of Surgeons.

[11]  K A Chester,et al.  Preclinical characterization and in vivo imaging studies of an engineered recombinant technetium-99m-labeled metallothionein-containing anti-carcinoembryonic antigen single-chain antibody. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[12]  A. Plückthun,et al.  Reliable cloning of functional antibody variable domains from hybridomas and spleen cell repertoires employing a reengineered phage display system. , 1997, Journal of immunological methods.

[13]  R. Schibli,et al.  Steps towards [(C5Me5)TcO3]: Novel synthesis of [(C5Me5)Tc(CO)3] from [{Tc(μ3−OH)(CO)3}4] and oxidation of [(C5Me5)M(CO)3] (M = Tc, Re) with Br2 , 1998 .

[14]  Roger Schibli,et al.  A Novel Organometallic Aqua Complex of Technetium for the Labeling of Biomolecules: Synthesis of [99mTc(OH2)3(CO)3]+ from [99mTcO4]- in Aqueous Solution and Its Reaction with a Bifunctional Ligand , 1998 .

[15]  T. Yokota,et al.  Differential metabolic patterns of iodinated versus radiometal chelated anticarcinoma single-chain Fv molecules. , 1992, Cancer research.

[16]  R. Hawkins,et al.  Clinical evidence of efficient tumor targetting based on single–chain Fv antibody selected from a combinatorial library , 1996, Nature Medicine.

[17]  K Dowlatshahi,et al.  Sentinel node biopsy in the staging of breast cancer. , 1998, American journal of surgery.

[18]  A. Plückthun,et al.  An intrinsically stable antibody scFv fragment can tolerate the loss of both disulfide bonds and fold correctly , 1998, FEBS letters.

[19]  A. Plückthun,et al.  Engineered turns of a recombinant antibody improve its in vivo folding. , 1995, Protein engineering.

[20]  M. Welch,et al.  Synthesis and biological evaluation of Tc-99m-cyclopentadienyltricarbonyltechnetium-labeled octreotide. , 1999, Nuclear medicine and biology.

[21]  A. Fritzberg.  Advances in 99mTc-Labeling of Antibodies , 1987, Nuklearmedizin.

[22]  Alun G. Jones,et al.  Synthesis and characterization of hexakis(alkyl isocyanide) and hexakis(aryl isocyanide) complexes of technetium(I) , 1983 .

[23]  R Weissleder,et al.  Design of metal-binding green fluorescent protein variants. , 1998, Biochimica et biophysica acta.

[24]  M. Stalteri,et al.  Comparison of the stability of technetium-labeled peptides to challenge with cysteine. , 1999, Bioconjugate chemistry.

[25]  R. Schibli,et al.  Reactions with the technetium and rhenium carbonyl complexes (NEt4)2[MX3(CO)3]. Synthesis and structure of [Tc(CN-But)3(CO)3](NO3) and (NEt4)[Tc2(μ-SCH2CH2OH)3(CO)6] , 1996 .

[26]  A. Plückthun,et al.  The Functional Expression of Antibody Fv Fragments in Ischhuchia coli: Improved Vectors and a Generally Applicable Purification Technique , 1991, Bio/Technology.

[27]  P. Bunn,et al.  Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess. , 1984, Journal of immunological methods.

[28]  B. Groner,et al.  Overexpression of the c‐erbB‐2 protein in human breast tumor cell lines , 1989, Journal of cellular biochemistry.

[29]  H. Weisman,et al.  Rapid infarct imaging with a technetium-99m-labeled antimyosin recombinant single-chain Fv: evaluation in a canine model of acute myocardial infarction. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[30]  Technetium-99m-sestamibi scintimammography for the detection of breast carcinoma: comparison between planar and SPECT imaging. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[31]  F. Podlaski,et al.  IL-12 receptor. I. Characterization of the receptor on phytohemagglutinin-activated human lymphoblasts. , 1992, Journal of immunology.

[32]  S. Vallabhajosula,et al.  Preclinical evaluation of technetium-99m-labeled somatostatin receptor-binding peptides. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.